Short- versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis | Zendy

Matthew E. Falagas | Zendy; Sophia G. Avgeri | Zendy; Dimitrios K. Matthaiou | Zendy; George Dimοpoulos | Zendy; Ilias Ι. Siempos | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Short- versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis

Author(s) -

Matthew E. Falagas,

Sophia G. Avgeri,

Dimitrios K. Matthaiou,

George Dimοpoulos,

Ilias Ι. Siempos

Publication year - 2008

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkn201

Subject(s) - medicine , exacerbation , relative risk , chronic bronchitis , adverse effect , confidence interval , randomized controlled trial , meta analysis , bronchitis , antimicrobial , cefixime , antibiotics , cephalosporin , chemistry , organic chemistry , microbiology and biotechnology , biology

The aim of this study was to evaluate the comparative effectiveness and safety of short (5 days) and long (7 or 10 days) duration antimicrobial treatment of patients with acute exacerbations of chronic bronchitis (AECB).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research